Areas of Expertise
Bladder Cancer
Better Bladder Cancer Management
About half of all bladder cancers are first found while the cancer is still only in the inner layer of the bladder wall. (These are non-invasive or in situ cancers.) About 1 in 3 bladder cancers have spread into deeper layers of the bladder wall but are still only in the bladder. In most of the remaining cases, the cancer has spread to nearby tissues or lymph nodes outside the bladder. Rarely (in about 5% of cases), it has spread to distant parts of the body.
Early and accurate diagnosis is crucial for effective bladder cancer treatment for optimizing treatment options, preserving bladder function, and improving quality of life – let our cystoscope be the accurate diagnostic tool you use to increase the chance of a favorable prognosis for your patient.
Uroessentials offers an advanced HD image for a highly accurate bladder cancer diagnosis.
Incontinence
Incredible Incontinence Diagnostics
Over 25 million adult Americans experience temporary or chronic urinary incontinence. Accurate identification of the type and cause of incontinence allows healthcare providers to develop personalized and targeted treatment plans. Different types of incontinence (urgency, stress, functional and overflow) may require distinct interventions for optimal management.
Positive detection of incontinence is essential for tailoring effective treatment plans, preventing complications, and promoting overall well-being. It empowers both healthcare providers and patients to address this common and often treatable condition.
When individuals understand the specific type of incontinence they are experiencing and the rationale behind their treatment plan, they are more likely to adhere to recommended interventions, leading to better treatment outcomes.
We offer the most cost effective incontinence diagnostic system choice on the market, the Uroessentials Uroflow.
Prostate Cancer
Prostate Cancer Management Perferred by Men*
Other than skin cancer, prostate cancer is the most common cancer in American men. Since 2014, the incidence rate has increased by 3% per year overall and by about 5% per year for advanced-stage prostate cancer.
The management of prostate cancer is vital for achieving the best possible outcomes, preserving quality of life, and addressing the diverse needs of individuals. Managing through a comprehensive and individualized approach ensures that treatment plans align with patients' goals and preferences throughout their cancer journey.
Uroessentials partners with HPS to offer HIFU through a mobile treatment platform for prostate cancer.
*for better quality of life outcomes
Oncological Patient Management
Outstanding Oncological Patient Management
Did you know Cystectomy patients have high readmission rate of 20-40%?
Uroessentials Oncological Patient Management program is designed to improve patient outcomes, increase care coordination, maximize staff efficiency, and reduce costs by positively impacting hospital readmissions, length of stay, care plan adherence, and patient safety.
How Uroessentials Oncological Patient Management program works:
Patients discharged with connected health wristwatch
Hospital care provider or Uroessentials nurse contacts patient to check-in on their progress
Patient data retrieved via secure clinician portal which is accessed by care providers
Clinician portal highlights data points that are above or below pre-determined safe values